AstraZeneca PLC (Germany) Insiders
| ZEG Stock | 124.55 0.05 0.04% |
AstraZeneca PLC employs about 83.5 K people. The company is managed by 10 executives with a total tenure of roughly 194834 years, averaging almost 19483.0 years of service per executive, having 8350.0 employees per reported executive. Breaking down AstraZeneca PLC's management performance can provide insight into the firm performance.
| Marc Dunoyer CEO CEO Officer |
| MBA DVM CEO CEO Director |
AstraZeneca |
AstraZeneca PLC Management Team Effectiveness
The company has return on total asset (ROA) of 0.0555 % which means that it generated a profit of $0.0555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities.AstraZeneca PLC Workforce Comparison
AstraZeneca PLC is rated fourth in number of employees category among its peers. The total workforce of Drug Manufacturers-General industry is at this time estimated at about 511,921. AstraZeneca PLC retains roughly 83,500 in number of employees claiming about 16% of equities under Drug Manufacturers-General industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. AstraZeneca PLC Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AstraZeneca PLC Price Series Summation is a cross summation of AstraZeneca PLC price series and its benchmark/peer.
AstraZeneca PLC Notable Stakeholders
An AstraZeneca PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AstraZeneca PLC often face trade-offs trying to please all of them. AstraZeneca PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AstraZeneca PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Marc Dunoyer | CEO Officer | Profile | |
| MBA DVM | CEO Director | Profile | |
| Pam Cheng | EVP Board | Profile | |
| Menelas Pangalos | EVP Board | Profile | |
| Aradhana MD | CFO Director | Profile | |
| Chris Sheldon | Head Relations | Profile | |
| Gonzalo Vina | Head Relations | Profile | |
| Katarina Ageborg | Chief Sustainability | Profile | |
| Jeffrey Pott | G Officer | Profile | |
| Ruud Dobber | Exec Unit | Profile |
About AstraZeneca PLC Management Performance
The success or failure of an entity such as AstraZeneca PLC often depends on how effective the management is. AstraZeneca PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AstraZeneca management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AstraZeneca management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in AstraZeneca PLC's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AstraZeneca PLC. Check AstraZeneca PLC's Beneish M Score to see the likelihood of AstraZeneca PLC's management manipulating its earnings.
AstraZeneca PLC Workforce Analysis
Traditionally, organizations such as AstraZeneca PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AstraZeneca PLC within its industry.AstraZeneca PLC Manpower Efficiency
Return on AstraZeneca PLC Manpower
| Revenue Per Employee | 531.1K | |
| Revenue Per Executive | 4.4B | |
| Net Income Per Employee | 30K | |
| Net Income Per Executive | 250.1M |
Additional Tools for AstraZeneca Stock Analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.